A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients.

Source:http://linkedlifedata.com/resource/pubmed/id/14997194

Br. J. Cancer 2004 Mar 8 90 5 985-90

Download in:

View as

Triples

General Info

PMID
14997194